Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 07/02/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/about/
Gimlet Labs, Inc. | $80,000,000 | (Mar 26, 2026)
Highlight(US) | $40,000,000 | (Mar 26, 2026)
BrainGrid | $1,000,000 | (Mar 26, 2026)
NOPALERA | $4,000,000 | (Mar 26, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Worth AI | $30,000,000 | (Mar 26, 2026)
Hanover Park | $27,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)
Talino Fintech Foundry | $7,500,000 | (Mar 26, 2026)
Doctronic | $40,000,000 | (Mar 26, 2026)
Thesis Care | $45,000,000 | (Mar 26, 2026)
Cleavr | $1,158,600 | (Mar 24, 2026)